Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-132174 |
Brand: | MCE |
CAS: | 2361289-44-1 |
MDL | - |
---|---|
Molecular Weight | 362.46 |
Molecular Formula | C23H26N2O2 |
SMILES | O=C(NC1=CC=C(C(C)(C)C#N)C=C1)C2=CC3=C(CCCCC3)C=C2OC |
CHIKV-IN-2 is a potent inhibitor against Chikungunya virus (CHIKV) , with excellent cellular antiviral activity ( EC 90 =270 nM) and improved liver microsomal stability. CHIKV-IN-2 shows inhibitory activity against a cellular target Dihydroorotate Dehydrogenase (DHODH) , which interacts with various viruses and regulate their replication via depleting intracellular pyrimidine pools [1] .
CHIKV-IN-2 (compound 8q) is a potent pan-alphavirus inhibitor, with EC
90
s of 0.85-2.5 μM for CHIKV clinical isolates and attenuated vaccine strains
[1]
.
CHIKV-IN-2 is active against alphavirus VEEV (EC
90
=0.40 μM) as well as flaviviruses such as West Nile Virus (WNV, EC
90
=0.20 μM) and Dengue Virus Strain-2 (DENV-2, EC
90
=0.60 μM)
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
CHIKV-IN-2 (compound 8q) (80 mg/kg; i.p. twice a day for 3 days) significantly decreases infectious CHIKV dissemination to other tissues of mice
[1]
.
CHIKV-IN-2 (40 mg/kg; p.o., i.p., s.c.) exhibits moderate bioavailability (F=41%, 43%, 4%), terminal elimination half-life (t
1/2
=9.9, 18.5, 18.6 h) and C
max
(642, 858, 90 ng/mL) in mice
[1]
.
CHIKV-IN-2 (1 mg/kg; i.v.) exhibits terminal elimination half-life (t
1/2
= 2.02 h) and AUC (497 h•ng/mL) in mice
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Female and male C57BL/6 mice [1] |
Dosage: | 80 mg/kg |
Administration: | I.p. twice a day for 3 days |
Result: |
Failed to inhibit virus loads at the site of infection.
Decreased virus dissemination to other tissues. |
Animal Model: | Male C57BL/6 mice were challenged with CHIKV in the right footpad [1] |
Dosage: | 1 mg/kg for i.v. and 40 mg/kg for p.o., i.p., s.c. (Pharmacokinetic Analysis) |
Administration: | I.v., p.o., i.p., s.c. |
Result: |
I.v.: t
1/2
= 2.02 h; AUC=497 h•ng/mL.
P.o.: F=41%; t 1/2 =9.9 h; C max =642 ng/mL. I.p.: F=43%; t 1/2 =18.5 h; C max =858 ng/mL. S.c.: F=4%; t 1/2 =18.6 h; C max =90 ng/mL. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 100 mg/mL ( 275.89 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.7589 mL | 13.7946 mL | 27.5893 mL |
5 mM | 0.5518 mL | 2.7589 mL | 5.5179 mL |
10 mM | 0.2759 mL | 1.3795 mL | 2.7589 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.